A Potential Role for Statins in the Long-term Reduction in the Risk of Neurodegenerative Disease

Authors

  • Chittaranjan Andrade Department of Clinical Psychopharmacology and Neurotoxicology, National Institute of Mental Health and Neurosciences, Bangalore, Karnataka, India

Keywords:

Statins, Alzheimer’s disease, Dementia, Parkinson’s disease, Meta-analysis, Observational studies

Abstract

Statins reduce the progression of cerebrovascular atherosclerosis and so may reduce the risk of vascular dementia. Statins may also reduce the formation of beta-amyloid and increase the clearance of amyloid precursor protein and so reduce the risk of Alzheimer's disease (AD). A meta-analysis of 46 longitudinal observational studies of statin therapy found that in all primary and almost all secondary analyses, statin use was associated with a lower risk of incident AD and all-cause dementia. A cohort study found that statin use was associated with a lower risk of development of Parkinson's disease (PD); the benefit appeared to be mediated by a lower risk of atherosclerosis. Whereas observational studies cannot establish a causal protective role for statins against dementia and PD, given that statins are primarily indicated for the prevention of ischemic cardiovascular and cerebrovascular events, whether or not they prevent dementia and PD is not relevant to their prescription; but if they do prevent these, it’s a bonus. It should be kept in mind that even if statins do play a significant preventative role in neurodegenerative disease, as with the benefits in the prevention of cardiovascular disease, the benefits will only be observed after many years or decades of treatment, and the numbers needed to treat will be large. Expressed otherwise, the effect size is likely to be small.

Downloads

Download data is not yet available.

References

Wolters FJ, Ikram MA. Epidemiology of vascular dementia. Arterioscler Thromb Vasc Biol. 2019;39(8):1542-1549.

Andrade C, Radhakrishnan R. The prevention and treatment of cognitive decline and dementia: An overview of recent research on experimental treatments. Indian J Psychiatry. 2009;51(1):12-25.

Olmastroni E, Molari G, De Beni N, et al. Statin use and risk of dementia or Alzheimer's disease: a systematic review and meta-analysis of observational studies. Eur J Prev Cardiol. 2022;29(5):804-814.

Oveisgharan S, Yu L, Barnes LL, et al. Association of statins with cerebral atherosclerosis and incident parkinsonism in older adults. Neurology. 2022;98(19):e1976-e1984.

Xuan K, Zhao T, Qu G, et al. The efficacy of statins in the treatment of Alzheimer's disease: a meta-analysis of randomized controlled trial. Neurol Sci. 2020;41(6):1391-1404.

McGuinness B, Craig D, Bullock R, et al. Statins for the prevention of dementia. Cochrane Database Syst Rev. 2016 Jan 4;(1):CD003160.

Downloads

Published

2022-12-23

How to Cite

Andrade, C. (2022). A Potential Role for Statins in the Long-term Reduction in the Risk of Neurodegenerative Disease. Indian Journal of Clinical Psychiatry, 2(02), 44–46. Retrieved from https://ijocp.com/index.php/IJOCP/article/view/58